23 employees
Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.
2012
$72M
from 5 investors over 5 rounds
Biointron Biological Inc. raised $72M on September 2, 2022
Investors: October Capital, CEBI, Jifeng Ventures 济峰资本, Shenzhen Co-Stone Asset Management and Haitong Securities